Home LiteratureArticle Details
PMID: 2660146 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease.

Musser JM, Mattingly SJ, Quentin R, Goudeau A, Selander RK

Abstract

Chromosomal genotypes of 128 isolates of six serotypes (Ia, Ib, Ic, II, Ic/II, and III) of Streptococcus agalactiae (group B Streptococcus) recovered predominantly from human infants in the United States were characterized by an analysis of electrophoretically demonstrable allelic profiles at 11 metabolic enzyme loci. Nineteen distinctive electrophoretic types (ETs), representing multilocus clonal genotypes, were identified. Mean genetic diversity per locus among ETs of isolates of the same serotype was, on average, nearly equal to that in all 19 ETs. Cluster analysis of the ETs revealed two primary phylogenetic divisions at a genetic distance of 0.65. A single clone (ET 1) represented by 40 isolates expressing type III antigen formed division I. Division II was composed of 18 ETs in three major lineages diverging from one another at distances greater than 0.35 and included strains of all six antigenic classes. The type III organisms in division I produce more extracellular neuraminidase and apparently are more virulent than the type III strains in division II, which are related to strains of other serotypes that cause disease much less frequently. The existence of this unusually virulent clone accounts, in major part, for the high morbidity and mortality associated with infection by type III organisms.

MeSH Terms
Genotype Humans Infant, Newborn Neuraminidase/biosynthesis Phylogeny Polymorphism, Genetic Serotyping Streptococcal Infections/microbiology Streptococcus agalactiae/genetics,isolation & purification,pathogenicity Virulence
Chemicals
Neuraminidase
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Musser J M
Department of Biology, Pennsylvania State University, University Park 16802.
Mattingly S J
Quentin R
Goudeau A
Selander R K
References (34)
34 references, click to expand
  1. Population genetics of pathogenic bacteria.
    Microb Pathog. 1987 Jul;3(1):1-7 PMID: 3332801
  2. Evolutionary genetics of the encapsulated strains of Haemophilus influenzae.
    Proc Natl Acad Sci U S A. 1988 Oct;85(20):7758-62 PMID: 2902639
  3. Growth of several cariogenic strains of oral streptococci in a chemically defined medium.
    Infect Immun. 1975 Apr;11(4):649-55 PMID: 1091546
  4. Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens.
    J Exp Med. 1975 Jul 1;142(1):165-79 PMID: 1097573
  5. The emergence of group B streptococci in infections of the newborn infant.
    Annu Rev Med. 1977;28:355-69 PMID: 324367
  6. Summary of the workshop on perinatal infections due to group B Streptococcus.
    J Infect Dis. 1977 Jul;136(1):137-52 PMID: 69669
  7. Extracellular neuraminidase production by group B streptococci.
    Infect Immun. 1977 Oct;18(1):189-95 PMID: 332641
  8. Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci.
    Infect Immun. 1978 Sep;21(3):738-46 PMID: 361576
  9. Extracellular neuraminidase production by clinical isolates of group B streptococci from infected neonates.
    J Clin Microbiol. 1980 Oct;12(4):633-5 PMID: 6999031
  10. Factors influencing release of type III antigens by group B streptococci.
    Infect Immun. 1981 Feb;31(2):615-23 PMID: 7012015
  11. Protease production by clinical isolates of type III group B streptococci.
    J Clin Microbiol. 1980 Sep;12(3):421-3 PMID: 7012176
  12. Correlation between the production of extracellular substances by type III group B streptococcal strains and virulence in a mouse model.
    Infect Immun. 1981 Nov;34(2):448-54 PMID: 7030959
  13. Association of elevated levels of cellular lipoteichoic acids of group B streptococci with human neonatal disease.
    Infect Immun. 1983 Mar;39(3):1243-51 PMID: 6341233
  14. Enzyme polymorphism and genetic population structure in Escherichia coli and Shigella.
    J Gen Microbiol. 1983 Sep;129(9):2715-26 PMID: 6355392
  15. Biosynthetic capacity for type-specific antigen synthesis determines the virulence of serotype III strains of group B streptococci.
    Infect Immun. 1984 May;44(2):217-21 PMID: 6370860
  16. The population genetics of Escherichia coli.
    Annu Rev Genet. 1984;18:31-68 PMID: 6099090
  17. Genetic diversity in relation to serotype in Escherichia coli.
    Infect Immun. 1985 Aug;49(2):407-13 PMID: 2410366
  18. Group B streptococcal vaccines.
    Rev Infect Dis. 1985 Jul-Aug;7(4):458-67 PMID: 3898306
  19. Kinetic and chemical analyses of the biologic significance of lipoteichoic acids in mediating adherence of serotype III group B streptococci.
    Infect Immun. 1985 Oct;50(1):107-15 PMID: 2995256
  20. The incidence of GBS disease in neonates in different countries.
    Antibiot Chemother (1971). 1985;35:17-27 PMID: 3901893
  21. Epidemiological aspects of human/animal interrelationship in GBS.
    Antibiot Chemother (1971). 1985;35:40-8 PMID: 3901908
  22. GBS enzymes, hemolysin, toxins and other products.
    Antibiot Chemother (1971). 1985;35:57-70 PMID: 3901911
  23. The genetics of GBS.
    Antibiot Chemother (1971). 1985;35:71-82 PMID: 2996419
  24. Clonal analysis of Escherichia coli O2:K1 isolated from diseased humans and animals.
    Infect Immun. 1986 Jan;51(1):268-76 PMID: 3510171
  25. Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics.
    Appl Environ Microbiol. 1986 May;51(5):873-84 PMID: 2425735
  26. Clonal analysis of descent and virulence among selected Escherichia coli.
    Annu Rev Microbiol. 1986;40:185-210 PMID: 3535645
  27. Group B streptococcal carriage and disease: a 6-year prospective study.
    J Pediatr. 1987 Jan;110(1):31-6 PMID: 3540249
  28. Clonal diversity in Haemophilus pleuropneumoniae.
    Infect Immun. 1987 May;55(5):1207-15 PMID: 3570461
  29. Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern.
    J Bacteriol. 1987 Jun;169(6):2781-92 PMID: 3108242
  30. Transposon mutagenesis of group B streptococcus beta-hemolysin biosynthesis.
    Infect Immun. 1987 Sep;55(9):2314-6 PMID: 3040595
  31. Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence.
    Proc Natl Acad Sci U S A. 1987 Oct;84(20):7208-12 PMID: 2823254
  32. In vitro method to differentiate isolates of type III Streptococcus agalactiae from symptomatic and asymptomatic patients.
    J Clin Microbiol. 1988 Apr;26(4):686-91 PMID: 3284898
  33. Clonal population structure of encapsulated Haemophilus influenzae.
    Infect Immun. 1988 Aug;56(8):1837-45 PMID: 2899551
  34. Comparison of clonal analysis and DNA restriction analysis for typing of Neisseria meningitidis.
    Microb Pathog. 1988 Jan;4(1):45-51 PMID: 3143892
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1989-06-00
Pages
4731-5
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC287347
Subset
IM
Grants
NIAID NIH HHS · AI-22380 · United States
NIAID NIH HHS · AI-24144 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]